Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Callio Therapeutics Inc.

Headquarters: Seattle, WA, United States of America
Year Founded: 2024
Status: Private

BioCentury | Mar 15, 2025
Editor's Commentary

The NewCo model spurs debate, but it’s about more than money — a Perspective

Expanding the dealmaker’s toolkit to bring Asian innovation to the West
BioCentury | Mar 7, 2025
Finance

Strategics back Trimtech’s protein cluster degraders with $31M: Finance Report

Pharma venture arms join founding investors CIC, DDF to back U.K. start-up; plus venture rounds for Garuda, Ataraxis and Callio, and Tenaya’s follow-on
BioCentury | Mar 4, 2025
Deals

Kyorin picks Novartis amid innovative push; Abbvie taps Gubra for obesity: Deals Report

Plus: Hummingbird/Callio, Bridgene/Takeda, Magnet/Lilly, Gensaic/Novo, and more
BioCentury | Mar 3, 2025
Deals

The dealmaking at the heart of the NewCo boom

Formed with Hummingbird assets, $187M, Callio brings trend to Singapore
Items per page:
1 - 4 of 4